The Food and Drug Administration (FDA) recently approved inhaled glucagon — a medication used to treat severe hypoglycemia in patients with diabetes. For decades, people suffering from severe hypoglycemia had to be treated with a rather cumbersome glucagon injection. But with the approval of inhaled glucagon, these individuals will now have a choice to inhale or inject their medication.
What is Severe Hypoglycemia?
Severe hypoglycemia typically occurs in people with diabetes who are using insulin to manage their blood glucose, or blood sugar, levels. Severe hypoglycemia occurs when blood sugar levels fall below 54 mg/dl, which causes you to become confused, unconscious, or suffer from other symptoms that require assistance from another person for recovery.
What is Glucagon?